Showing 221 - 240 results of 292 for search 'T62 (classification)', query time: 0.11s Refine Results
  1. 221
  2. 222
  3. 223
  4. 224

    Diagnostic accuracy of drooling, reluctance, oropharynx, others, and leukocytosis score as a predictor of mortality and complications following acute corrosive ingestion by Fawaz Poonthottathil, Soorya Suresh, Jamshed Nayer, Praveen Aggarwal

    Published 2023-10-01
    “…Similarly, DROOL score ≤5 has a sensitivity of 81.7% and a specificity of 62.5% in predicting the development of mortality. …”
    Get full text
    Article
  5. 225

    Artificial intelligence in breast cancer survival prediction: a comprehensive systematic review and meta-analysis by Zohreh Javanmard, Saba Zarean Shahraki, Kosar Safari, Abbas Omidi, Sadaf Raoufi, Mahsa Rajabi, Mohammad Esmaeil Akbari, Mehrad Aria

    Published 2025-01-01
    “…Hybrid models, combining traditional and modern ML techniques, were mostly considered to predict survival rates (40.62%). Supervised learning was the dominant ML paradigm (75%). …”
    Get full text
    Article
  6. 226

    Retrospective evaluation of autotransfusion using a cell saver device versus allotransfusion in the perioperative management of acute hemoperitoneum in 43 dogs (2017–2021) by Fabienne Blunschi, Dennis Gluding, Esther Hassdenteufel, Matthias Schneider, Hendrik Lehmann

    Published 2025-02-01
    “…The classification into blood transfusion groups was as follows: 7/43 (16.3%) in the AA-group, 11/43 (25.6%) in the AO-group, 11/43 (25.6%) in the CS-group and 14/43 (32.6%) in the NT-group. …”
    Get full text
    Article
  7. 227

    Burden of Myasthenia Gravis in the Czech Republic: Analysis of the Nationwide Patient Registry by Stanislav Voháňka, Aleš Tichopád, Magda Horáková, Jana Junkerová, Michala Jakubíková, Jiří Piťha, Michaela Týblová, Daniela Vlažná, Katarína Breciková, Jacek Cudny, Petr Hájek

    Published 2024-12-01
    “…We analyzed the following disease-related endpoints: myasthenia gravis composite (MGC) score, forced vital capacity (FVC), and Myasthenia Gravis Foundation of America (MGFA) clinical classification. Results The incidence showed a consistent increasing trend from 0.62 to 3.13. …”
    Get full text
    Article
  8. 228

    Treatment Patterns and Healthcare Costs Among Patients with Stroke and Spasticity: A 2-Year Longitudinal Study by Michael Hull, Vamshi Ruthwik Anupindi, Jing He, Mitchell DeKoven, Jumaah Goldberg, Jonathan Bouchard

    Published 2024-12-01
    “…Mean all-cause healthcare costs were US$62,875 among patients with PSS versus $44,472 among patients without (P < 0.001), representing 39.6% higher adjusted all-cause healthcare costs among patients with PSS versus patients without PSS. …”
    Get full text
    Article
  9. 229
  10. 230

    Multimorbidity patterns and function among adults in low- and middle-income countries: a scoping review by Karina Berner, Quinette A Louw, Eugene Nizeyimana, Diribsa Tsegaye Bedada

    Published 2025-01-01
    “…The International Classification of Functioning, Disability and Health framework was used to classify functional problems.Results Nine studies (total sample size: 62 003) were included, mainly from upper-middle-income Asian countries. …”
    Get full text
    Article
  11. 231

    Associations of the Need for Surgery in Emergency Department Patients with Small Bowel Obstructions by Daniel J. Berman, Alexander W. Mahler, Ryan C. Burke, Andrew E. Bennett, Nathan I. Shapiro, Leslie A. Bilello

    Published 2024-11-01
    “…We included adult patients admitted to the emergency department (ED) with the International Classification of Diseases, 10th Rev, codes for small bowel obstruction from June 1, 2017– May 30, 2019. …”
    Get full text
    Article
  12. 232
  13. 233

    Effectiveness and utilization of a cognitive screening program for primary geriatric care by David P. Salmon, Anna Malkina, Melanie L. Johnson, Christina Gigliotti, Emily A. Little, Douglas Galasko

    Published 2025-01-01
    “…Medical records documented discussion of screening results with the patient in 69% of cases (80% if MCI or dementia was detected) and often referral to a specialist (62%), new brain imaging (54%), or change in medication (58%) when screening indicated potential cognitive impairment. …”
    Get full text
    Article
  14. 234

    COVID-19's impact on hospital stays, mortality, and readmissions for poverty-related diseases, noncommunicable diseases, and injury groups in Thailand. by Satiti Palupi, Kyaw Ko Ko Htet, Vorthunju Nakhonsri, Chumpol Ngamphiw, Peerapat Khunkham, Sanya Vasoppakarn, Narumol Atthakul, Sissades Tongsima, Chantisa Keeratipusana, Watcharapot Janpoung, Virasakdi Chongsuvivatwong

    Published 2024-01-01
    “…For non-communicable diseases, the respective proportions in the prolonged LOS were 9.0%, 9.12%, and 7.58%, with respective hospital mortality being 10.65%, 8.86%, 6.62%, and readmissions were 17.79/1,000, 13.94/1,000, 13.19/1,000, respectively. …”
    Get full text
    Article
  15. 235
  16. 236
  17. 237

    Medicaid Eligibility and Time to Re-incarceration Among Previously Incarcerated Subjects With Schizophrenia by Chris Kozma, Michael Dickson, Jacqueline Pesa, Carmela J. Benson

    Published 2016-10-01
    “…Subjects were included if they had a schizophrenia diagnosis (International Classification of Diseases, 9th Revision, Clinical Modification [ICD- 9-CM] code 295.xx), were between the ages of 18 and 62, and had been released from incarceration. …”
    Get full text
    Article
  18. 238

    Association between diabetes mellitus and total hip arthroplasty outcomes: an observational study using the US National Inpatient Sample by Jasvinder A Singh, Sumanth Chandrupatla, Kranti Rumalla

    Published 2024-07-01
    “…In multivariable-adjusted logistic regression in the overall cohort, diabetes was associated with higher odds of a longer hospital stay (adjusted OR (aOR) 1.38; 95% CI 1.35 to 1.41), higher total charges (aOR 1.11; 95% CI 1.09 to 1.13), non-routine discharge (aOR 1.18; 95% CI 1.15 to 1.20), the need for blood transfusion (aOR 1.19; 95% CI 1.15 to 1.23), postprocedural infection (aOR 1.62; 95% CI 1.10 to 2.40) and periprosthetic joint infection (aOR 1.91; 95% CI 1.12 to 3.24). …”
    Get full text
    Article
  19. 239

    Exploring the clinical significance of anti-acetylcholine receptor antibody titers, changes, and change rates in Myasthenia Gravis by Lijun Luo, Xinyi Zhu, Chunbei Wen, Yifan Guo, Jie Yang, Dongsheng Wei, Ping Yu, Mei Wan

    Published 2025-01-01
    “…This study aims to explore the relationship between AChR-Ab titers and AChR-Ab rate of change (RR-AChR-Ab, %) and MG scores.MethodsWe used a prospective study approach, and included 62 patients with generalized MG (GMG) who were positive for AChR-Ab. …”
    Get full text
    Article
  20. 240

    Prognostic stratification of patients with AJCC 2018 pN1 disease in stage III oral squamous cell carcinoma by Ming-Hsien Tsai, Hui-Ching Chuang, Yu-Tsai Lin, Tai-Lin Huang, Fu-Min Fang, Hui Lu, Chih-Yen Chien

    Published 2022-04-01
    “…The patients with pT1N1 disease showed better 5-year overall survival (OS), disease specific survival (DSS), and disease free survival (DFS) than those with pT2-3N1 disease (pT1N1 vs pT2-3N1, OS: 96.4% vs 72.2%, p = 0.004; DSS: 96.4% vs 77.3%, p = 0.021; DFS: 84.6% vs 62.3%, p = 0.023). Besides, there was no potential clinicopathological confounder which is significant associated with different pathological T classifications in this unique cohort. …”
    Get full text
    Article